4//SEC Filing
Ulsh Gordon A 4
Accession 0001181431-10-063679
CIK 0001295976other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 7:24 PM ET
Size
7.9 KB
Accession
0001181431-10-063679
Insider Transaction Report
Form 4
Ulsh Gordon A
Director
Transactions
- Disposition to Issuer
Stock Option
2010-12-27−4,654→ 0 totalExercise: $11.45Exp: 2020-01-27→ Common Stock (4,654 underlying) - Disposition to Issuer
Common Stock
2010-12-27$12.00/sh−1,923$23,076→ 0 total
Footnotes (2)
- [F1]On December 27, 2010, a wholly owned subsidiary of Clearwater Paper Corporation merged with Cellu Tissue Holdings, Inc. pursuant to a merger agreement entered into between Clearwater Paper and Cellu Tissue on September 15, 2010 (the "Merger"), as more fully described in the Cellu Tissue proxy statement dated December 1, 2010 filed with the SEC. Each share of common stock of Cellu Tissue was converted into $12.00 in cash. Cellu Tissue board of directors approved the disposition by the Reporting Person in the Merger.
- [F2]In connection with the Merger, each outstanding Cellu Tissue option to purchase shares of common stock, whether or not vested, was cancelled and Reporting Person received a cash payment in an amount equal to the number of shares of common stock represented by each option, vested or unvested, multiplied by the excess, if any, of $12.00 over the exercise price per share under each option. Reporting Person's disposition of options in the Merger was approved by the Cellu Tissue board of directors.
Documents
Issuer
Cellu Tissue Holdings, Inc.
CIK 0001295976
Entity typeother
Related Parties
1- filerCIK 0001321501
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 7:24 PM ET
- Size
- 7.9 KB